Hashimoto's thyroiditis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The mainstay of therapy for Hashimoto's thyroiditis is synthetic levothyroxine. Corticosteroids and selenium can also be used in certain cases.
The mainstay of therapy for [[Hashimoto's thyroiditis]] is [[Levothyroxine|synthetic levothyroxine]]. [[Corticosteroid]]<nowiki/>s and [[selenium]] can also be used in certain cases.
==Medical Therapy==
==Medical Therapy==
The drugs used in the treatment of Hashimoto's thyroiditis are:<ref name="pmid24434360">{{cite journal |vauthors=Caturegli P, De Remigis A, Rose NR |title=Hashimoto thyroiditis: clinical and diagnostic criteria |journal=Autoimmun Rev |volume=13 |issue=4-5 |pages=391–7 |year=2014 |pmid=24434360 |doi=10.1016/j.autrev.2014.01.007 |url=}}</ref>
The drugs used in the treatment of Hashimoto's thyroiditis are:<ref name="pmid24434360">{{cite journal |vauthors=Caturegli P, De Remigis A, Rose NR |title=Hashimoto thyroiditis: clinical and diagnostic criteria |journal=Autoimmun Rev |volume=13 |issue=4-5 |pages=391–7 |year=2014 |pmid=24434360 |doi=10.1016/j.autrev.2014.01.007 |url=}}</ref><ref name="pmid25266247">{{cite journal |vauthors=Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM |title=Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement |journal=Thyroid |volume=24 |issue=12 |pages=1670–751 |year=2014 |pmid=25266247 |pmc=4267409 |doi=10.1089/thy.2014.0028 |url=}}</ref>
#Levothyroxine:
#[[Levothyroxine]]:
#*lifelong synthetic levothyroxine (L-T4) is used to treat the hypothyroidism in Hashimoto's disease.
#*lifelong synthetic [[levothyroxine]] (L-[[T4]]) is used to treat the hypothyroidism in Hashimoto's disease.
#Corticosteroids:
#*Main goals of levothyroxine replacement therapy are:
#*A short course of glucocorticoids can be used in the treatment of IgG4-related variant of Hashimoto's thyroiditis.
#**Resolution of the [[hypothyroid]] symptoms and signs including biological and physiologic markers of [[hypothyroidism]]
#Selenium:
#**Normalization of serum [[thyrotropin]] with improvement in thyroid hormone concentrations
#*Dietary selenium supplementation is considered to be protective against the autoimmune diseases of the thyroid.
#**To avoid overtreatment (iatrogenic thyrotoxicosis)
#*Side effects include [[atrial fibrillation]] and [[osteoporosis]]
#[[Corticosteroid|Corticosteroids]]:
#*A short course of [[glucocorticoids]] can be used in the treatment of IgG4-related variant of Hashimoto's thyroiditis.
#[[Selenium]]:
#*Dietary [[selenium]] supplementation is considered to be protective against the [[autoimmune diseases]] of the [[thyroid]].


Drug Regimen:
Drug Regimen:
*Synthetic levothyroxine (L-T4) 1.6–1.8 μg/kg of body weight per day orally.
*[[Levothyroxine (oral)|Synthetic levothyroxine]] (L-[[T4]]) 1.6–1.8 μg/kg of body weight per day orally.


==References==
==References==
Line 23: Line 28:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Needs content]]
 
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]

Latest revision as of 21:58, 29 July 2020

Hashimoto's thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hashimoto's thyroiditis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hashimoto's thyroiditis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hashimoto's thyroiditis medical therapy

CDC on Hashimoto's thyroiditis medical therapy

Hashimoto's thyroiditis medical therapy in the news

Blogs on Hashimoto's thyroiditis medical therapy

Directions to Hospitals Treating Hashimoto's thyroiditis

Risk calculators and risk factors for Hashimoto's thyroiditis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

The mainstay of therapy for Hashimoto's thyroiditis is synthetic levothyroxine. Corticosteroids and selenium can also be used in certain cases.

Medical Therapy

The drugs used in the treatment of Hashimoto's thyroiditis are:[1][2]

  1. Levothyroxine:
    • lifelong synthetic levothyroxine (L-T4) is used to treat the hypothyroidism in Hashimoto's disease.
    • Main goals of levothyroxine replacement therapy are:
      • Resolution of the hypothyroid symptoms and signs including biological and physiologic markers of hypothyroidism
      • Normalization of serum thyrotropin with improvement in thyroid hormone concentrations
      • To avoid overtreatment (iatrogenic thyrotoxicosis)
    • Side effects include atrial fibrillation and osteoporosis
  2. Corticosteroids:
    • A short course of glucocorticoids can be used in the treatment of IgG4-related variant of Hashimoto's thyroiditis.
  3. Selenium:

Drug Regimen:

References

  1. Caturegli P, De Remigis A, Rose NR (2014). "Hashimoto thyroiditis: clinical and diagnostic criteria". Autoimmun Rev. 13 (4–5): 391–7. doi:10.1016/j.autrev.2014.01.007. PMID 24434360.
  2. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM (2014). "Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement". Thyroid. 24 (12): 1670–751. doi:10.1089/thy.2014.0028. PMC 4267409. PMID 25266247.

Template:WH Template:WS